Synthomer (LON:SYNT)‘s stock had its “buy” rating reaffirmed by stock analysts at Deutsche Bank in a research report issued to clients and investors on Friday, ThisIsMoney.Co.Uk reports.
Several other research firms have also commented on SYNT. UBS Group reiterated a “sell” rating on shares of in a research report on Monday, June 24th. Barclays reiterated an “underweight” rating on shares of in a research report on Thursday, July 4th. Credit Suisse Group set a €50.00 ($58.14) price target on shares of Fresenius SE & Co KGaA and gave the company a “neutral” rating in a research report on Monday, May 6th. JPMorgan Chase & Co. lowered their price target on shares of National Grid from GBX 1,000 ($13.07) to GBX 960 ($12.54) and set an “overweight” rating on the stock in a research report on Thursday, May 23rd. Finally, Peel Hunt reiterated a “hold” rating and issued a GBX 935 ($12.22) price target (up from GBX 920 ($12.02)) on shares of Antofagasta in a research report on Tuesday, July 9th. Two equities research analysts have rated the stock with a sell rating, one has given a hold rating and six have given a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average price target of GBX 484.90 ($6.34).
SYNT stock opened at GBX 359.60 ($4.70) on Friday. The firm has a 50 day simple moving average of GBX 370.32. The firm has a market capitalization of $1.22 billion and a price-to-earnings ratio of 12.32. Synthomer has a 12 month low of GBX 345 ($4.51) and a 12 month high of GBX 580.50 ($7.59). The company has a quick ratio of 0.84, a current ratio of 1.22 and a debt-to-equity ratio of 65.20.
Synthomer plc operates as a specialty chemicals company in Europe, North America, Asia, and internationally. The company offers pressure-sensitive adhesives, acrylic polymers, acrylic dispersions, and other adhesives; latices for foamed bedding products and footwear; and binders for carpet applications.
Read More: Gap Down Stocks
Receive News & Ratings for Synthomer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synthomer and related companies with MarketBeat.com's FREE daily email newsletter.